Article
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
Annals of neurology - 1 Apr 2015
Findlay Andrew R, Wein Nicolas, Kaminoh Yuuki, Taylor Laura E, Dunn Diane M, Mendell Jerry R, King Wendy M, Pestronk Alan, Florence Julaine M, Mathews Katherine D, Finkel Richard S, Swoboda Kathryn J, Howard Michael T, Day John W, McDonald Craig, Nicolas Aurélie, Le Rumeur Elisabeth, Weiss Robert B, Flanigan Kevin M
Abstract excerpt
OBJECTIVE: Exon-skipping therapies aim to convert Duchenne muscular dystrophy (DMD) into less severe Becker muscular dystrophy (BMD) by altering pre-mRNA splicing to restore an open reading frame, allowing translation of an internally deleted and partially functional dystrophin protein. The most common single exon deletion-exon 45 (Δ45)-may theoretically be treated by skipping of either flanking exon (44 or 46)....
Topics
Join the communities discussing this publication.
